Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Some snow showers. Cold with a frost and icy stretches.
Police in Lancashire are to make a new appeal for information about missing schoolgirl Charlene Downes before Blackpool play Brighton
The animals at Knowsley Safari Park, some of home aren't used to a British winter, have been braving the snow.